Evidence map›Paper›PMID 41822289›Full record

ArticleFrontiers in gastroenterology (Lausanne, Switzerland)2025

Evaluating bowel preparation tolerability in IBD: a phase 3

Gian Eugenio Tontini, Alessandro Rimondi, Flavio Caprioli, Giovanni Aldinio, Luca Pastorelli, Franco Radaelli, Cristiano Spada, Maurizio Vecchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in gastroenterology (Lausanne, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gian Eugenio TontiniDepartment of Pathophysiology and Organ Transplantation, University of Milan, Milan, Italy.
Alessandro RimondiDepartment of Pathophysiology and Organ Transplantation, University of Milan, Milan, Italy.
Flavio CaprioliDepartment of Pathophysiology and Organ Transplantation, University of Milan, Milan, Italy.
Giovanni AldinioDepartment of Pathophysiology and Organ Transplantation, University of Milan, Milan, Italy.
Luca PastorelliDepartment of Health Sciences, University of Milan, Milan, Italy.
Franco RadaelliGastroenterology Unit, Valduce Hospital, Como, Italy.
Cristiano SpadaDigestive Endoscopy Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Maurizio VecchiDepartment of Pathophysiology and Organ Transplantation, University of Milan, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bowel preparation is a significant challenge for patients undergoing colonoscopy, especially in Inflammatory Bowel Disease (IBD) patients. Oral mannitol (OM), an ultra-low-volume, single-dose osmotic laxative with a sweet taste, could improve patient tolerability. We performed a

Indexed as

bowel preparationcolonoscopyCrohn’s diseaseinflammatory bowel diseaseoral mannitolpatient tolerabilitypolyethylene glycolulcerative colitis

Identifiers

PMID41822289
PMCPMC12952433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.